For instance, in a study involving soft tissue sarcomas by Pinheiro et al, different localizations of MCT1 were found to predict varying prognoses: cytomembrane localization of MCT1 was linked to a poor prognosis, while nuclear localization was associated with a better outcome (18). The gene discussed is SLC16A1; the disease is soft tissue sarcoma.